• 대한정형외과학회지
• /
• 제55권2호
• /
• pp.169-177
• /
• 2020

목적: 요추부 후측방 유합술 시 자가골과 혼합 이식하는 골대체재의 종류에 따른 골유합률을 비교하여 효과적인 혼합 이식 재료를 제시하고자 한다. 대상 및 방법: 본 연구는 후측방 유합술 시행 후 최소 2년 추시한 환자들을 대상으로 후향적으로 시행하였으며 유합술 시 국소 자가골에 혼합하여 사용한 이식 재료에 따라 네 군으로 분류하였다. I군은 대퇴 골두 동종골을 사용한 48예, II군은 β-tricalcium phosphate를 사용한 38예, III군은 이상인산칼슘을 사용한 92예, IV군은 이상인산칼슘 및 자가 골수를 사용한 38예를 대상으로 하였다. 술 후 2년째 단순 방사선 검사를 추시하여 유합 여부와 임상결과로 판단하였으며, 단순 방사선 소견상 양측 상하 횡돌기간에 뚜렷하게 형성된 골괴와 함께 굴신 방사선 소견상 각 운동 범위가 2도 미만이면서 전위 소견이 보이지 않을 때 유합으로 정의하였다. 결과: 술 후 2년째 단순 방사선을 추시한 결과 이상인산칼슘 및 자가골수를 국소 자가골과 혼합 이식한 IV군에서 가장 높은 유합률을 나타냈다. 결론: 생체흡수성이 높아지고 기계적 강도가 보완된 골전도성 대체재인 이상인산칼슘과 골유도 및 골형성이 가능한 자가 골수의 물질적 특성이 골유합률을 높일 수 있을 것이다. 따라서 요추부 후측방 유합술 시 이상인산칼슘, 자가 골수 및 국소 자가골의 혼합 이식이 자가골 이식을 효과적으로 대체할 수 있는 방법으로 사용될 수 있으리라 생각된다.

• Journal of the Korean Data and Information Science Society
• /
• 제9권2호
• /
• pp.149-158
• /
• 1998

본 논문에서는 환자의 수명과 치료횟수의 모형화를 위해 공변량을 포함한 결합모형을 개발하고자 한다. 개발된 모형을 Autologous Blood and Marrow Ttansplant Registry에 등록된 환자의 자료에 적용하여 모형에 포함된 모수의 추론과정을 논의하고자 한다.

• Biotechnology and Bioprocess Engineering:BBE
• /
• 제11권4호
• /
• pp.364-367
• /
• 2006

In order to enhance the repair of defects in articular cartilage via cell therapy with autologous chondrocytes, as well as with periosteum-derived progenitor cells (PDPCs), silkworm hemolymph (SH) and a variety of cartilage-specific extracellular matrices (ECMs) including type II collagen, proline, chondroitin 4-sulfate, and chondroitin 6-sulfate were assessed with regard to their efficacy as media supplements. SH, a known anti-apoptotic agent, was found to enhance cell growth, as was shown by the results of a 3-(4,5-dimethylthiazol-2yl)-2,5-diphenyltetrazolium bromide (MTT) assay. According to the results of reverse transcriptase polymerase chain reaction (RT-PCR) analyses, the cartilage-specific ECMs were found to stimulate the expression of hyaline cartilage-specific genes, most notably type II collagen and Sox9, in monolayer cultures of PDPCs.

• Journal of Chest Surgery
• /
• 제28권3호
• /
• pp.247-252
• /
• 1995

The isolated coronary ostial stenosis is rare and a critical lesion which requires urgent surgical intervention. Recently direct angioplasty is assumed as a preferable approach to conventional bypass grafting. From Mar. 1990 to Aug. 1993, six patients underwent direct angioplasty in Sejong Heart Institute. The mean age of 6 patients was 48 years [range 37 to 63 and they consisted with 5 females and one male. All had severe angina [class III or IV of short duration [mean 5.3 months and a low incidence of risk factors. Despite the crucial location of the lesion, most patients had well preserved left ventricular function and normal wall motion. We performed direct angioplasty with autologous pericardium via anterior approach except one patient who underwent direct angioplasty and CABG. One patient died 4 hours after angioplasty probably due to acute coronary dissection. The survived 5 patients maintain normal life without symptoms during 26.2 months follow up [range 5 to 47 months .Our preliminary results suggest that angioplasty of isolated coronary ostial stenosis in highly selected patient can be carried out with good results and relatively low operative risks.

• Journal of Chest Surgery
• /
• 제23권2호
• /
• pp.260-267
• /
• 1990

During a eight month period[from December, 1988 to July, 1989], a series of 35 adults undergoing redo-valve replacement or coronary artery bypass grafting was selected to an autotransfusion group[n=10] or a control group[n=25]. The Cell Saver System[Haemonetics Corp., Graintree, Mass] was employed for autotransfusion. With this system, all blood shed in the operative field before and after cardiopulmonary bypass and remained in cardiotomy reservoir after cardiopulmonary bypass was aspirated by means of a locally heparinized collecting system. After the salvaged blood was centrifuged, the resulting red cell concentrate subsequently reinfused. The patients receiving autologous blood required significantly less banked homologous blood than their controls[3213k1020 ml and 506051931 ml, respectively: p=0.001] There were no clinical infections in the autotransfusion group, although 40% of the cultures of processed blood were positive. And there was no apparent intergroup difference of the clinical and the hematologic and hemostatic laboratory findings. We conclude that autotransfusion using cell saver is effective for saving the homologous blood transfusion in cardiac surgery.

• Journal of Chest Surgery
• /
• 제31권10호
• /
• pp.1009-1013
• /
• 1998

대동맥근부를 포함한 대동맥 판막 심내막염은 적극적인 내과적 및 외과적 치료를 해도 염증의 재발이나 사망률이 높은 질환이다. 자가폐동맥판막을 이용하여 전대동맥근부치환술은 이식편이 생체 조직이고, 면역학적으로도 안전한 조직이라 술후 항응고요법이 요구되지 않는 술식이다. 저자들은 38세된 여자환자에서 대동맥근부를 포함한 대동맥 판막 심내막염 환자에서 Ross술식을 이용하여 성공적으로 치험하였고 수술후 3개월간 추적중 양호한 상태이다.

• The Korean Journal of Pain
• /
• 제10권1호
• /
• pp.109-112
• /
• 1997

Spontaneous intracranial hypotension(SIH) is a rare syndrome of spontaneously occurring postural headache associated with low CSF pressure. It usually occur without evidence of any preceeding events such as lumbar puncture, back trauma, operative procedure, or medical illness. This syndrome usually resolves spontaneously or with strict bed rest. When the headache persists or is incapacitating, more aggressive treatment may be necessary. Autologous epidural blood patch is highly effective in the management of SIH. We experienced a case of SIH with downward displacement of brain in MRI and successfully treated with epidural blood patch.

• The Korean Journal of Pain
• /
• 제10권1호
• /
• pp.104-108
• /
• 1997

Spontaneous intracranial hypotension, a syndrome of low CSF pressure, occurs without preceding events such as lumbar puncture, back trauma, operative procedure or medical illness. The most characteristic symptom is an occipital or frontal headache which is aggrevated in the erect position and relieved in the supine position. This syndrome usually resolves spontaneously or with strict bed rest. When the headach persists or is incapacitating, more aggressive treatment may be necessary. Autologous epidural blood patch is highly effective in the management of spontaneous intracranial hypotension. Epidural blood produces an organized clot which effectively tamponade any dural CSF leak. The rapid relief of headache immediately after the infusion of blood occur by some other mechanism, such as an increase in subarachnoid pressure that is known to occur with infusion of fluid into the lumbar epidural space. We report three cases of spontaneous intracranial hypotension successfully treated with epidural blood patch.

• Journal of Korean Neurosurgical Society
• /
• 제61권3호
• /
• pp.302-311
• /
• 2018

Atypical teratoid rhabdoid tumours (ATRTs) are the most common malignant central nervous system tumours in children ${\leq}1year$ of age and represent approximately 1-2% of all pediatric brain tumours. ATRT is a primarily monogenic disease characterized by the bi-allelic loss of the SMARCB1 gene, which encodes the hSNF5 subunit of the SWI/SNF chromatin remodeling complex. Though conventional dose chemotherapy is not effective in most ATRT patients, high dose chemotherapy with autologous stem cell transplant, radiotherapy and/or intrathecal chemotherapy all show significant potential to improve patient survival. Recent epigenetic and transcriptional studies highlight three subgroups of ATRT, each with distinct clinical and molecular characteristics with corresponding therapeutic sensitivities, including epigenetic targeting, and inhibition of tyrosine kinases or growth/lineage specific pathways.

• Archives of Plastic Surgery
• /
• 제47권5호
• /
• pp.392-403
• /
• 2020

Severe cartilage defects and congenital anomalies affect millions of people and involve considerable medical expenses. Tissue engineering offers many advantages over conventional treatments, as therapy can be tailored to specific defects using abundant bioengineered resources. This article introduces the basic concepts of cartilage tissue engineering and reviews recent progress in the field, with a focus on craniofacial reconstruction and facial aesthetics. The basic concepts of tissue engineering consist of cells, scaffolds, and stimuli. Generally, the cartilage tissue engineering process includes the following steps: harvesting autologous chondrogenic cells, cell expansion, redifferentiation, in vitro incubation with a scaffold, and transfer to patients. Despite the promising prospects of cartilage tissue engineering, problems and challenges still exist due to certain limitations. The limited proliferation of chondrocytes and their tendency to dedifferentiate necessitate further developments in stem cell technology and chondrocyte molecular biology. Progress should be made in designing fully biocompatible scaffolds with a minimal immune response to regenerate tissue effectively